144
Views
11
CrossRef citations to date
0
Altmetric
RADIOSENSITIVITY IN CKD PATIENTS

Radiosensitivity in patients suffering from chronic kidney disease

, , , , , , , & show all
Pages 172-178 | Received 16 May 2014, Accepted 25 Aug 2014, Published online: 16 Oct 2014

References

  • Abdelhafiz AH, Brown SH, Bello A, El Nahas M. 2010. Chronic kidney disease in older people: Physiology, pathology or both? Nephron Clin Pract 116:19–24.
  • Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L, Vral A. 2002. Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87:1379–1385.
  • Baeyens A, Slabbert JP, Willem P, Jozela S, Van Der Merwe D, Vral A. 2010. Chromosomal radiosensitivity of HIV positive individuals. Int J Radiat Biol 86:584–592.
  • Bhatia A, Kumar Y. 2013. Cancer cell micronucleus: An update on clinical and diagnostic applications. APMIS 121:569–581.
  • Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Cebulska-Wasilewska A, Fabianova E, Fucic A, Hagmar L, Joksic G, Martelli A, Migliore L, Mirkova E, Scarfi MR, Zijno A, Norppa H, Fenech M. 2007. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625–631.
  • Bonassi S, El-Zein R, Bolognesi C, Fenech M. 2011. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: Evidence from human studies. Mutagenesis 26:93–100.
  • Christiakov DA, Voronova NV, Chistiakov PA. 2008. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncol 47:809–824.
  • Church D, Midgley R, Kerr D. 2012. Biomarkers in early-stage colorectal cancer: Ready for prime time? Dig Dis 30(Suppl. 2):27–33.
  • Demircigil GC, Aykanat B, Fidan K, Gulleroglu K, Bayrakci US, Sepici A, Buyukkaragoz B, Karakayali H, Haberal M, Baskin E, Buyan N, Burgaz S. 2011. Micronucleus frequencies in peripheral blood lymphocytes of children with chronic kidney disease. Mutagenesis 26:643–650.
  • Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V. 2010. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: Prospective population based cohort study. BMJ 341:c4986.
  • Fenech M. 2007. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084–1104.
  • Fragedaki E, Nebel M, Schupp N, Sebekova K, Völkel W, Klassen A, Pischetsrieder M, Frischmann M, Niwa T, Vienken J, Heidland A, Stopper H. 2005. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis. Nephrol Dial Transplant 20:1936–1943.
  • Huumonen K, Korkalainen M, Boman E, Heikkilä J, Höytö A, Lahtinen T, Luukkonen J, Viluksela M, Naarala J, Juutilainen J. 2014. Dose- and time-dependent changes of micronucleus frequency and gene expression in the progeny of irradiated cells: Two components in radiation-induced genomic instability? Mutat Res 765:32–39.
  • Kobras K, Schupp N, Nehrlich K, Adelhardt M, Bahner U, Vienken J, Heidland A, Sebekova K, Stopper H. 2006. Relation between different treatment modalities and genomic damage of end-stage renal failure patients. Kidney Blood Press Res 29:10–17.
  • Lialiaris T, Mavromatidou P, Digkas E, Passadaki T, Mpountoukas P, Panagoutsos S, Vargemezis V. 2010. Chromosome instability in patients with chronic renal failure. Genet Test Mol Biomarkers 14:37–41.
  • Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC. 2012. Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol 2012:691369.
  • Little JB. 1998. Radiation-induced genomic instability. Int J Radiat Biol 74:663–671.
  • Malachi T, Zevin D, Gafter U, Chagnac A, Slor H, Levi J. 1993. DNA repair and recovery of RNA synthesis in uremic patients. Kidney Int 44:385–389.
  • Moreno-Palomo J, Hernández A, Creus A, Marcos R. 2014. Genomic instability in newborn with short telomeres. Plos One 9:e91753.
  • Mozdarani H, Mansouri Z, Haeri SA. 2005. Cytogenetic radiosensitivity of G0-lymphocytes of breast and esophageal cancer patients as determined by micronucleus assay. J Radiat Res 46:111–116.
  • Negrini S, Gorgoulis VG, Halazonetis TD. 2010. Genomic instability – an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11:220–228.
  • Nemec AA, Wallace SS, Sweasy JB. 2010. Variant base excision repair proteins: Contributors to genomic instability. Semin Cancer Biol 20:320–328.
  • Rao SN. 2009. Cancer screening in end-stage renal disease. Saudi J Kidney Dis Transpl 20:737–740.
  • Rangel-López A, Paniagua-Medina ME, Urbán-Reyes M, Cortes-Arredondo M, Alvarez-Aguilar C, López-Meza J, Ochoa-Zarzosa A, Lindholm B, García-López E, Paniagua JR. 2013. Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: A comparative study. Mutagenesis 28:219–225.
  • Rodríguez-Ribera L, Stoyanova E, Corredor Z, Coll E, Silva I, Diaz JM, Ballarin J, Marcos R, Pastor S. 2014. Time in hemodialysis modulates the levels of genetic damage in hemodialysis patients. Environ Mol Mutagen 55:363–368.
  • Sandoval SB, Stoyanova E, Coll E, Pastor S, Reyes J, Andrés E, Ballarin J, Xamena N, Marcos R. 2010. Glomerular filtration rate index is associated with genetic damage in chronic renal failure patients. Mutagenesis 25:603–608.
  • Savina NV, Smal MP, Kuzhir TD, Egorova TM, Khurs OM, Polityko AD, Goncharova RI. 2012. Biomarkers for genome instability in some genetic disorders: A pilot study. Biomarkers 17:201–208.
  • Schinzel R, Munch G, Heidland A, Sebekova K. 2001. Advanced glycation end products in end-stage renal disease and their removal. Nephron 87:295–303.
  • Schupp N, Dette EM, Schmid U, Bahner U, Winkler M, Heidland A, Stopper H. 2008a. Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients. Naunyn Schmiedebergs Arch Pharmacol 378:283–291.
  • Schupp N, Schmid U, Heidland A, Stopper H. 2008b. New approaches for the treatment of genomic damage in end-stage renal disease. J Ren Nutr 18:127–133.
  • Schupp N, Heidland A, Stopper H. 2010. Genomic damage in end-stage renal disease-contribution of uremic toxins. Toxins 2:2340–2358.
  • Sera N, Hida A, Imaizumi M, Nakashima E, Akahoshi M. 2013. The association between chronic kidney disease and cardiovascular disease risk factors in atomic bomb survivors. Radiat Res 179:46–52.
  • Sterpone S, Cornetta T, Padua L, Mastellone V, Giammarino D, Testa A, Tirindelli D, Cozzi R, Donatto V. 2010. DNA repair capacity and acute radiotherapy adverse effects in Italian breast cancer patients. Mutat Res 684:43–48.
  • Stopper H, Treutlein AT, Bahner U, Schupp N, Schmid U, Brink A, Perna A, Heidland A. 2008. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. Nephrol Dial Transplant 23:3272–3279.
  • Stoyanova E, Sandoval SB, Coll E, Zúñiga LA, El-Yamani N, Coll E, Pastor S, Reyes J, Andrés E, Ballarin J, Xamena N, Marcos R. 2010. Genotoxic damage in chronic renal failure patients. Studies using the Comet assay. Nephrol Dial Transplant 25:879–885.
  • Stoyanova E, Pastor S, Coll E, Collins A, Marcos R. 2014. Base excision repair capacity in chronic renal failure patients undergoing hemodialysis treatment. Cell Biochem Funct 32:177–182.
  • Surrallés J, Xamena N, Creus A, Catalán J, Norppa H, Marcos R. 1995. Induction of micronuclei by five pyrethroid insecticides in whole-blood and isolated human lymphocyte cultures. Mutat Res 341:169–184.
  • Tampe B, Zeisberg M. 2013. Contribution of genetics and epigenetics to progression of kidney fibrosis. Nephrol Dial Transplant 29(suppl 4):iv72–;iv79.
  • Teschner M, Garte C, Ruckle-Lanz H, Mader U, Stopper H, Klassen A, Heidland A. 2002. Incidence and spectrum of malignant disease among dialysis patients in North Bavaria. Dtsch Med Wochenschr 127:2497–2502.
  • Thomay K, Schienke A, Vajen B, Modlich U, Schambach A, Hofmann W, Schlegelberger B, Göhring G. 2014. Chromosomal instability and telomere shortening in long-term culture of hematopoietic stem cells: Insights from a cell culture model of RPS14 haploinsufficiency. Cytogenet Genome Res 142:14–20.
  • Torres-Bugarín O, Zavala-Cerna MG, Nava A, Flores-García A, Ramos-Ibarra ML. 2014. Potential uses, limitations, and basic procedures of micronuclei and nuclear abnormalities in buccal cells. Dis Markers 2014:24778463.
  • Vral A, Fenech M, Thierens H. 2011. The micronucleus assay as a biological dosimeter of in vivo ionising radiation exposure. Mutagenesis 26:11–17.
  • Weiner DE. 2007. Causes and consequences of chronic kidney disease: Implications for managed health care. J Manag Care Pharm 13:S1–9.
  • Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P, Craig JC. 2009. Association of CKD and cancer risk in older people. J Am Soc Nephrol 20:1341–1350.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.